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A B S T R A C T
Our aim was to evaluate the adipose tissue percentage content appraised with BIA in patients recently treated for car-
diovascular disorders by means of surgery or percutaneous coronary interventions. Study included 208 consecutive pa-
tients, in age range 25–84 years, 176 male and 32 female. There were 108 (51.9%) percutaneous coronary interventions
and 100 (48.1%) operations. Adipose tissue share appraised by BIA in our settings was 28.6±6.7% with significant dif-
ferences in relation with gender (p<0.001) and no relations with the age of patients. Intermediate levels of correlations
were found in relation to the body mass index (Rho: 0.521, p<0.001), waist-circumference (Rho: 0.450; p<0.001) and
hip-circumference (Rho: 0.393; p<0.001). ROC-analyzes revealed diagnostic cutoff point of BIA at 29.5% for predicting
the obesity (AUC=0.761; p<0.001) and 27% for metabolic syndrome (AUC=0.715; p<0.001). There were no relations of
BIA to nutritional status, laboratory or echocardiography diagnostic. BIA offered clinically relevant appraisal of anthro-
pometrically and metabolic related risks from cardiovascular continuum. Diagnostic yields solely on impedance analyze
bases seem limited, particularly in investigational settings with composited endpoints.
Key words: BIA-bioelectrical impedance analyzes, postoperative rehabilitation, ischemic heart disease, valvular
heart disease, coronary artery bypass graft, PCI-percutaneous coronary intervention, nutritional risk
Introduction
The concept of bioelectrical analyzes is known in med-
icine for over a 140 years. However, technical advance-
ments in last few decades lead to development of non-in-
vasive and more sensitive diagnostic devices with supple-
mentary functions to relatively accurate predict body
composition1. Applying of electricity that is insensible to
body receptors, having satisfying safety profile and not
being expensive made it widely available bedside diag-
nostics2.
Bioelectrical impedance analyzes (BIA) measures the
resistance of body tissues, to flow of weak alternating
electrical currents, typically less than 1 mA and 50 kHz
frequencies. Impedance represents the summation of the
tissue resistances and reactance due to capacitance of the
membranes, tissue interfaces and non-ionic tissue share.
Resistance is dominantly due to through muscles flow. In
general BIA offers reliable estimation of body water con-
tents. Appraisal of fat free mass and adipose tissue share
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in body consents is done indirectly through the body wa-
ter content and standardization with known values of
tested populations3. Reproducibility of bioelectrical im-
pendences analyzes for body compositions depends on
several factors as hydration status including edema and
ascites, eating and drinking, recent vigorous muscle ac-
tivity, air humidity or temperature4. The exact patho-
physiology of bioelectrical impedance analyzes content is
not known and could change within various perspectives
of considerations as cellular, tissue, multi-organ, inter-
-individual or clinical5. Effects of tissue reparation, in-
flammation or invasive treatments as surgery were not
studied so far. Furthermore analyzes in relation to prev-
alence and extent of different chronic underlying dis-
eases backgrounds are uncommon6. Diagnostic profits
of numerous and widely available commercial devices
for bioelectrical impedance analyzes are not entirely
evident7.
Due to global epidemic of cardiovascular diseases
most of the adult and senior populations from the com-
munity represent common yet non-physiological refer-
ence range8. Non-negligible deal of health related ad-
verse effects within cardiovascular risks continuum is
mediated through body composition and subsequent pa-
thophysiological changes9,10. Studies have established re-
lations of the free fat or muscle mass or it’s lost with ad-
verse clinical and health related outcomes in more than a
several diseases11–14. Our aim was to evaluate the bio-
electrical impedance analyzes of adipose tissue share in
patients with known cardiovascular disease and relation
to invasiveness of treatment previous to rehabilitation.
Secondarily, assessment of bioelectrical impendences cli-
nical behavior was done in connections with anthropom-




Patients sample included population of Mediterra-
nean Caucasians scheduled for cardiovascular rehabilita-
tion program after completing acute settings treatment
for ischemic or valvular heart disease. Medical records on
treatments previous to rehabilitation were available for
the entire studied population. The timeline of rehabilita-
tion commencements was 1–6 months after acute treat-
ment, protocol included single routine cardiovascular re-
habilitation reevaluation and there was no follow up.
Diagnostic evaluation comprised of anthropometrics, la-
boratory tests, echocardiography and nutritional risk
screening.
Individuals with known contraindications for cardiac
rehabilitation, including intense acute illnesses or ad-
vanced chronic disease, including malignant diseases,
disorders of thyroid, uncompensated heart failure, with
clinically overt presence of edema or anasarca were not
included.
Main outcome measures
Bioelectrical impedance analyzes: Body adipose share
was appraised by commercially available hand held im-
pedance analyzer using tetra-polar electrode method (8
touch electrodes, frequency ranges 5, 50, 250 kHz) and
expressed as percentages (%). Technical characteristics
of the device: Current 500 µA; Input height 100~200 cm;
Measuring range 100~950 W; Measuring weight 10~250
kg; BMI calculation; Waist circumference in cm; Hip cir-
cumference in cm; Percentage of body adipose tissue; Ap-
plicable age: 5~89 years old; Measuring time within 30
seconds; Operation ambient-Temperature 10~40°C; Hu-
midity 30~75% (non-condensing); Storage ambient: Tem-
perature –20~60°C. Power consumption: 30 VA; Power
supply: AC 100~230 V, 50/60 Hz; Display: Graphic liquid
crystal display (320 x 480 pixel); Printing device: 25 pin
parallel printer.
Anthropometrics and nutritional status
Body mass index (BMI; kg/m2) was calculated using
standard formula and body type classifications. Waist
and hip circumferences (WC, HC) were measured by one
trained nurse using tape-meter expressed in centimeters
including calculation of circumferences ratios (WHR).
Nutritional risk was calculated using the NRS-2002
screening tool validated by the European Society for
Clinical Nutrition and Metabolism (ESPEN)15. NRS-2002
includes in the calculation extent and timeline of invol-
untary weight loss, disease severity and age >70 years.
Nutritional risk score appraisal ranges between 0 and 7.
Conventional grades of nutritional risk include: no risk
(NRS-2002=0), low risk (NRS-2002=1–3) and high risk
(NRS-2002³3).
Laboratory diagnostics
Blood samples were obtained in morning hours 07:30–
08:30 from brachial vein after overnight fasting. The fol-
lowing parameters were assessed: complete blood count
(CBC) with number of erythrocytes (ERC) multiplied by
1012, hematocrit (HCT) in L/L, mean corpuscular eryth-
rocyte volume (MCV) in fL, number of thrombocytes
(TRC) multiplied by 109; leukocyte count (LKC) multi-
plied by 109 with differential subpopulation analysis.
Biochemical analysis included alanine aminotransferase
(ALT) in IU/L at 37°C, aspartate aminotransferase (AST)
in IU/L at 37°C, gamma glutamyl transferase (GGT) in
IU/L at 37°C, serum glucose in mmol/L, total cholesterol
(CHOL) in mmol/L, low density lipoprotein (LDL) in
mmol/L, high density lipoprotein (HDL) in mmol/L, tri-
glycerides (TG) in mmol/L, creatinine (CR) in mmol/L,
urea in mmol/L, uric acid (UA) in mmol/L and thyro-
tropine i.e. thyroid stimulating hormone in mIU/L. Se-
lected data were presented in the tables, with notion of
clinical relevance.
Transthoracic echocardiography
Echocardiography was performed by two high
throughput cardiologists following guidelines of the Eu-
ropean Society for Cardiology and European Association
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of Echocardiography, on Toshiba »Artida« device apply-
ing the PST30BT 3 MHz cardiology transducer. For the
purposes of this study, targeted diagnostics included as-
sessment of left ventricle dimensions, regional and global
systolic function, global left ventricle ejection fraction
(LVEF) using biplane Simpson modified calculation.
Classes of left ventricle systolic dysfunction included
endpoint points of left ventricle systolic function set at
41% and 50%. Doppler analysis included velocity and
pressures of transaortic flow, transmitral flow evaluation
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TABLE 1














<45 14 (6.73%) 11 (10.19%) 3 0.085 26.6±6.9 0.108
45<65 107 (51.44%) 69 (63.89%) 38 <0.001 29.1±5.3 0.375
³65 87 (40.38%) 28 (25.93%) 59 <0.001 28.4±8.1 0.979
Gender




Female 32 (15.38%) 15 (13.89%) 17 34.9±6.5
Systolic function
LVEF ³50 136 (67.33%) 69 (63.89%) 70 0.569 29.1±6.9 0.200
LVEF ³41 163 (80.69%) 84 (77.78%) 83 0.068 29.0±6.9 0.070
BMI grade




25<30 105 (50.48%) 54 (50.00%) 51 28.0±5.6
30<35 71 (34.13%) 41 (37.96%) 30 32.2±6.6
³35 1 (0.48%) 0 (0.00%) 1 35.1±n/a
Nutritional risk
No risk (NRS 0) 3 (1.44%) 2 (1.85%) 1
<0.001
26.5±4.6
0.397Mild risk (NRS 1<3) 41 (19.71%) 40 (37.04%) 1 28.0±4.5
High risk (NRS ³3) 164 (78.75%) 66 (61.11%) 98 28.8±7.2
Smoking
Never 73 (36.14%) 29 (26.85%) 45
<0.001
27.9±7.3
0.768Active 54 (26.73%) 42 (38.89%) 14 28.9±8.0
Former 75 (37.13%) 37 (34.26%) 41 29.1±6.7
Cardiovascular risk
Hypertension 189 (90.87%) 102 (94.44%) 93 0.667 28.8±6.8 0.127
Hypercholesterolemia 189 (90.87%) 104 (96.30%) 91 0.115 28.7±6.8 0.328
Metabolic syndrome 177 (85.10%) 96 (88.89%) 87 0.676 29.2±6.6 0.005
Obese 64 (30.77%) 41 (37.96%) 26 0.072 32.6±6.5 <0.001
Diabetes 63 (30.29%) 33 (30.56%) 34 0.595 29.9±8.1 0.056
Glucose intolerance 41 (19.71%) 17 (15.74%) 25 0.097 27.7±7.3 0.623
Chronic renal disease 57 (27.40%) 16 (14.81%) 45 <0.001 28.3±7.3 0.405
COPD 36 (17.31%) 14 (12.96%) 25 0.026 29.4±6.7 0.248
Atrial fibrillation 23 (11.06%) 8 (7.41%) 15 0.081 27.8±7.1 0.971
SD – standard deviations; LVEF – left ventricle ejection fraction; BMI – body mass index; NRS – nutritional risk screen (NRS-2002);
COPD – chronic obstructive pulmonary disease; APD – any psychological disturbance. Differences within groups of treatment were as-
sessed using Chi square. Kruskal-Wallis ANOVA for ranks was used to test the differences of adipose tissue percentage appraised with
BIA to clinical paramters. Statistical significance defined with p<0.05.
of diastolic function and indirect quantification of pul-
monary artery systolic pressure (PAP).
Other investigations: Standard supine resting 12–led
electrocardiogram (ECG) with assessment of heart rate
and rhythm in terms of sinus or atrial fibrillation was
performed in all patients. Pulmonary status and chronic
obstructive pulmonary disease (COPD) prevalence and
severity were evaluated using a spirometer.
Ethical issues
Study was permitted by the University Hospital »Tha-
lassotherapia Opatija« ethical committee in line with the
good clinical practice. Patients were included after sign-
ing the informed consent. There were no grants or finan-
cial compensations for patients and investigators in-
volved in the study.
Statistical analyses
Statistical analyses were performed by a statistician
using Statistica 10 for Windows. Data were analyzed
with descriptive statistic and are presented as mean ±
standard deviation. Population demographics, comorbi-
dities, and nutritional risk scores were compared be-
tween groups using Pearson’s Chi square test. Numeric
data as anthropometrics, laboratory, and echocardiogra-
phy were analyzed by Mann-Whitney U-test. Numeric
difference of BIA within studied groups was explored by
Kruskal-Wallis ANOVA by ranks. Correlation of NRS-
2002 score with clinical outcomes was investigated by
Spearman Rho. Receiver operating curve analyzes was
done on MedCalc for windows version 12.2.1.0.A p<0.05
was considered statistically significant.
Results
Patients
Two hundred and eight successive patients, in range
25–85 years, average age 61.9±11.3. Females represen-
ted 15.4% of the cohort (N=31) and males 84.6% (N=
171). Patients’ characteristics are presented in Table 1.
Cardiologic treatments prior to rehabilitation
108 patients (52%) underwent percutaneous coronary
intervention (PCI) and 100 patients (48%) underwent
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TABLE 2
BIOELECTRICAL IMPEDANCE ANALYZES APPRAISED ADIPOSE TISSUE SHARE (%) IN RELATION WITH
PATIENT CHARACTERISTICS AND STUDIED GROUPS OF TREATMENT
N (patients)
=208




WhitneyPatients characteristics Mean±SD Spearman Rho p X±SD X±SD
Age (years) 61.9±11.3 0.024 0.733 58.1±10.8 66.0±10.5 <0.001
Height (m) 1.74±0.09 –0.295 <0.001 1.75±0.08 1.72±0.09 0.031
Weight (kg) 86.6±14.7 0.228 0.001 89.4±14.7 83.6±14.2 <0.001
BMI (kg/m2) 28.62±3.86 0.521 <0.001 29.08±3.86 28.10±3.82 0.031
Waist circumference (cm) 102.0±9.9 0.450 <0.001 103.5±9.6 100.4±9.9 0.008
Hip circumference (cm) 102.6±7.9 0.393 <0.001 103.2±6.6 101.9±9.2 0.032
WH ratio (n/n) 0.99±0.09 0.158 0.025 1.00±0.08 0.98±0.09 0.133
Adipose tissue(%)– by BIA 28.6±6.7 1.000 n/a 29.8±5.1 27.3±7.9 0.009
Nutritional risk (NRS-2002) 3.7±1.6 –0.040 0.574 2.6±1.0 5.0±1.0 <0.001
Cardiovascular diagnostics
ECG-frq (min) 69.6±11.2 –0.092 0.192 65.8±9.3 73.8±11.6 <0.001
Hematocrit 0.40±0.05 0.144 0.040 0.42±0.04 0.37±0.04 <0.001
Serum glucose (mmol/L) 6.9±1.9 0.211 0.003 6.9±2.1 7.0±1.9 0.102
Bilirubine (umol/L) 13.2±6.8 –0.174 0.013 13.3±7.1 13.1±6.6 0.852
Urea (umol/L) 7.11±2.35 0.116 0.100 6.78±2.50 7.46±2.13 0.002
Creatinine (mmol/L) 110.3±40.6 –0.121 0.086 99.8±28.9 121.6±47.9 <0.001
Cholesterol (mmol/L) 4.50±2.54 0.131 0.064 3.95±1.03 5.12±3.43 <0.001
LDL (mmol/L) 2.40±1.04 0.021 0.770 2.08±0.87 2.75±1.11 <0.001
LVEDd (mm) 53.7±6.0 0.038 0.596 54.7±6.2 52.78±5.6 0.038
LVEF (%) 50.3±8.0 0.027 0.704 49.7±8.57 50.9±7.4 0.342
AV PG (mmHg) 11.7±8.8 –0.006 0.935 8.89±4.80 14.8±10.8 <0.001
PCI – percutaneous coronary intervention; BMI – body mass index; WH – waist over hip ratio; ECG – electrocardiography; LDL – low
density lipoprotein; LVEDd – left ventricle end diastolic dimension; LVEF – left ventricle systolic function; AVPG – aortic valve peak
flow gradient.
surgery (c2 p=0.579). Surgical procedures included coro-
nary artery bypass graft (CABG; N=83) and valvular
surgery (VS; N=28) p=0.013 and p<0.001 respectively).
Eleven of valvular operations were accompanied by
CABG due to clinically relevant coronary artery disease.
Age group distribution (i.e., <45 years, 45–65 years, and
³65 years) was similarly distributed in other than young-
er of 45 years (c2 p<0.001; p=0.677; p=0.085;), and
there were noticed significant differences in terms of pa-
tients age distributions within treatments for middle and
older age-groups (p<0.001). Left ventricle ejection frac-
tion was in range of 25–65%, without significant differ-
ences between the studied treatments.
There were no differences between treatment groups
in body mass index grades (p=0.276), gender (p=0.534),
tested anthropometrics and cardiovascular comorbidi-
ties/risk factors whilst difference was found in: chronic
renal disease (p<0.001), nutritional risk (p<0.001), smo-
king status (p<0.001) and chronic obstructive pulmo-
nary disease (p<0.026). Prevalence of atrial fibrillation,
diabetes, grades of left ventricle systolic functions were
also not of significant difference between treatment groups
(p=0.081; p=0.595; p=0.569; p=0.068 respectively). Av-
erage nutritional risk by NRS-2002 score was 3.7±1.6
with significant difference in relation to treatments (Mann
Whitney U-test p<0.001) and nutritional risk grades
groups in relation to treatments (Pearson c2 p<0.001).
Single clinically relevant difference of studied diagnos-
tics between treatment groups was with creatinine (p=
0.002); Table 2.
Bioelectrical impedance analyzes appraised adipose
tissue share was 28.6%±6.7%, in range 7.3 to 48.9%. Ta-
ble 1 and 2. Statistically significant differences in rela-
tion to gender (p<0.001); and statistically significant and
clinically irrelevant (p=0.009) difference between treat-
ments. There were no significant differences in adipose
mass percentage according to bioelectrical impedance an-
alyzes within nutritional risk grades (Kruskal-Wallis
ANOVA by ranks; p=0.397) or studied groups of age <45
(p=0.108); 45–65 years (p=0.375) and ³65 years (p=
0.979). Difference was significant in relation to the body
mass index grades (Kruskal-Wallis ANOVA by ranks;
p<0.001) and metabolic syndrome prevalence (p=0.005).
Adipose tissue percentage appraised by bioelectrical
impedance analyzes clinically correlated with the body
mass index (Rho 0.521; p<0.001), waist circumferences
(Rho 0.450; p<0.001) and hip circumferences (Rho 0.393;
p<0.001). There were no clinically relevant correlations
with studied laboratory or echocardiography recordings.
Significant but weak discordance in correlations of adi-
pose tissue percentage by BIA was observed in between
percutaneous coronary interventions (Rho=0.185; p=
0.009) and the surgery group(Rho=–0.185; p=0.009). No
significant correlations of BIA to valvular surgeries were
established (Rho=–0.067; p=0.344).
Receiver operating curve analyzes (ROC) revealed di-
agnostic potential of bioelectrical impedance analyzes for
detecting the prevalence of obesity (AUC 0.761; p<0.001)
and metabolic syndrome (AUC 0.715; p<0.001) (Figure 1
and 2).
Traditional anthropometrics were also significantly
connected with prevalence of obesity and of similar diag-
nostic accuracy as bioelectrical impedance analyzes. ROC
analysis of waist circumference (WC) found critical cut-
off point of 105 cm implicative for diagnosing the obesity.
Statistical significance p<0.001; AUC=0.876. Sensitivity
78.46% (95%CI: 66.5–87.7); specificity 86.33% (95%CI:
79.5–91.6); positive likelihood ratio 5.74 (95%CI: 5.0–
6.6); negative likelihood ratio 0.25 (95%CI: 0.1–0.5).
ROC analysis of hip circumference (HC) found critical
cutoff point of 104 cm suggestive for diagnosing the obe-
sity. Statistical significance p<0.001; AUC=0.763. Sensi-
tivity 70.31% (95%CI: 57.6–81.1); specificity 76.98%
(95%CI: 69.1–83.7); positive likelihood ratio 3.05 (95%CI:
2.5–3.7); negative likelihood ratio 0.39 (95%CI: 0.2–0.6).
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Obesity (BMI > 30 kg/m 2)
















Fig. 1. Diagnostic accuracy of bioelectrial impedance for obesity
using ROC analyzis. Statistical significance p<0.001; AUC=
0.761. Value 29.5%; sensitivity 76.56% (95%CI: 64.3–86.2); speci-
ficity 71.01% (95%CI: 62.7–78.4); positive likelihood ratio 2.64
(95%CI: 2.2–3.1); negative likelihood ratio 0.33 (95%CI: 0.2–0.6).
Metabolic syndrome
















Fig. 2. Diagnostic accuracy of bioelectrical impedance for detec-
tion of metabolic syndrome using ROC analysis. Statistical sig-
nificance p<0.001; AUC=0.715. Critical cutoff value 27%; sensi-
tivity 66.10% (95%CI: 58.6–73.0); specificity 72.00% (95%CI:
50.6–87.9); positive likelihood ratio 2.36 (95%CI: 1.8–3.1); nega-
tive likelihood ratio 0.47 (95%CI: 0.2–0.9).
Discussion
Appraisal of body configuration and nutritional risk
came to focus of investigations due to confirmed clinical
value and correlations with health-related outcomes16,17.
Several of body configurations indexes were earlier found
to be the landmark of adverse prognosis in patients with
myocardial infarction and chronic heart failure18,19.
However, abundance of various devices in the market
makes recognition of clinical relevance rather difficult.
Our study appraised bioelectrical impedance analyzes of
body adipose tissue share in relation with comorbidities,
clinical diagnostics, nutritional risk, ischemic or valvular
heart disease backgrounds and invasiveness of treat-
ments prior to rehabilitation.
Adipose tissue share appraised by BIA in our settings
was 28.6±6.7% and showed significant differences in re-
lation with gender and anthropometrically based cardio-
vascular risks, and there were no relation with age of pa-
tients. Intermediate levels of correlations were found in
relation to the body mass index average values20. Signifi-
cant differences with weaker and incongruent correla-
tion trends were found between body mass index inputs.
Body weight was positively correlated with BIA out-
comes, whilst body height showed significantly negative
trends20. Output range of BIA was similar and corre-
sponding with body types within standardized BMI gra-
des. Highly significant correlations of ranks of bioele-
ctrical impedance judged body adipose tissue share were
found in relation with traditional anthropometrics as
waist circumference, hip circumference and their ra-
tios21. Later implies noteworthy dubious on presumed
body adipose share prediction by bioelectrical impedance
analyzes per se since named anthropometrics are the de-
vice based inputs and of results conceptualized on math-
ematical approximations to the reference populations.
Interesting relations in BIA outcomes were found with
prevalence of metabolic syndrome, occurrence of which
was not differently distributed between the treatment
group analyzes. Cutoff point of adipose share estimated
at 27% by bioelectrical impedance diagnostic device made
significant model of predicting the metabolic syndrome,
while cutoff point of 29.5% made significant prediction of
obesity prevalence22. Other studied cardiovascular risk
factors, beside the obesity were not of significant differ-
ences in terms of BIA outcomes. One must not disregard
relatively high prevalence of cardiovascular risks was
still nowadays found in our patients, particularly smok-
ing which raises the questions for further health ini-
tiatives23,24. Typical cardiovascular rehabilitation labora-
tory and echocardiography diagnostic did not reveal dif-
ferences in terms of bioelectrical impedance appraisal of
adipose tissue contents. Left ventricle systolic function
dynamics within tested set of patients or studied groups
was not differently distributed and there were no rela-
tions with BIA outcomes.
The differences of BIA in relation with bases of acute
treatments prior to rehabilitation were significant but of
close output range, hence with minor clinical or diagnos-
tic implications. Those seemed to be for the most influ-
enced by difference in weight of 5.8 kg between the
groups of treatments and in the amounts corresponding
to slight difference of 0.98 BMI units. Interestingly pa-
tients treated with percutaneous coronary interventions
were of clinically relevant higher average weights than
patients with surgical treatments, although on expected
bases of diabetes, metabolic syndrome and joined coro-
nary risk factors that made them indirectly more prone
to surgical revascularizations one would expect the oppo-
site trend. On the other hand surgical patients displayed
meaningfully higher nutritional risks, attributable with
invasiveness of acute treatments and in great part re-
sponsible for the observed mean weight difference25.
Higher nutritive risk in surgical patients was also in line
with greater prevalence and overt clinical diagnostics dif-
ferences of chronic renal and chronic obstructive pulmo-
nary diseases, which both are established nutritional risk
factors26. Clinically relevant connections to the nutri-
tional risk appraised by the standardized NRS-2002
questionnaire were failed to be recognized in the BIA
diagnostics27. Differences in BIA outcomes in relation
with post-surgical healing and alternated tissue charac-
teristics were of weakly opposite correlation trends, how-
ever diagnostic implications on these bases would be rhe-
torical, mainly due to noted weight and body mass index
differences that showed greater influence on impedance
appraisal of body adipose tissue share28. Observed labo-
ratory differences between the treatment groups did not
have implications on the BIA outcomes, were within or
close to referral ranges representing unspecific repara-
tory response in the post-surgical period.
There were no adverse reactions or symptoms sugges-
tive for ischemic chest pain as well as the sensations of
the electricity were reported during testing of patients
with bioelectrical impedance analyzes.
Although diagnostic yields of bioelectrical impedance
analyzes devices seem limited on sole bases of impedance
analyzes, devices of similar characteristics seems to offer
fair and clinically relevant appraisal of anthropometri-
cally and metabolic related risks from cardiovascular
continuum29. However, data on bioelectrical impedance
analyzes could frequently be found included as inputs in
various clinical studies which might be challenging issue
for conclusions and reproducibility. BIA outcome data do
not seem to be influenced in significant manner by the
invasiveness of treatment and testing does not bring con-
spicuous health related risks. Bioelectrical impedance
analyzes devices with combined anthropometrical inputs
contribute relevantly to appraisal of general cardiovascu-
lar risk in terms of primary and secondary prevention fa-
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ANALIZA BIOELEKTRI^NE IMPEDANCE NUDI KLINI^KI RELEVANTNU PROCJENU TJELESNE
GRA\E, NO SUBOPTIMALNA JE ZA PROCJENU NUTRITIVNOG RIZIKA ILI RAZLIKA IZME\U
KIRU[KIH BOLESNIKA I LIJE^ENIH PCI-OM
S A @ E T A K
Cilj istra`ivanja bio je analizirati udio masnog tkiva u ukupnoj masi tijela, procijenjen metodom bioelektri~ne im-
pedance(otpora) (BIA) kod bolesnika koji su zbog kardiovaskularne bolesti lije~eni operativnim putem ili perkutanom
koronarnom intervencijom (PCI). Uklju~eno je 208 uzapstopnih bolesnika, u dobi 25–84 godine, 176 mu{kih i 32 `ene.
Od toga je bilo 108 (51,9%) lije~enih PCI i 100 (48,1%) operiranih. Procjena udjela masnog tkiva u ukupnoj masi procije-
njena pomo}u BIA je iznosila 28,6±6,7%, uz zna~ajne razlike prema spolu (p<0,001), dok nije bilo zna~ajnosti u pogle-
du dobi. Intermedijarni stupanj korelacije prona|en je prema indeksu tjelesne mase (Rho: 0,521; p<0,001), opsegu
struka (Rho: 0,450; p<0,001), opsegu bokova (Rho: 0,393; p<0,001). Pomo}u ROC analize vrijednosti udjela adipoznog
tkiva ³29,5% bile su prijelomne za dijagnosticiranje pretilosti (AUC=0,761; p<0,001), dok su iznosi ³27% bili dijagno-
sti~ki za metaboli~ki sindrom (AUC=0,715; p<0,001). Nije bilo statisti~ki zna~ajnih odnosa BIA s nutritivnim statu-
som, laboratorijskom ili ehokardiografskom dijagnostikom. U zaklju~ku, testiranje pomo}u BIA nudilo je relevantnu
klini~ku procjenu antropolo{ki i metaboli~ki povezanih rizika iz kardiovaskularnog kontinuuma. No, dijagnosti~ka po-
uzdanost BIA u pogledu kompleksnih klini~kih ishoda ~ini se limitirana.
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